- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
What Is Human Serum Albumin and How It Drives Modern Medicine
Feb 25, 2026
Takeda’s $1.7B AI Drug Discovery Deal with Iambic Signals Shift
Feb 10, 2026
Brazil Vitamin K2 Market is expected to reach US$ 9.81 million by 2028
Jun 09, 2023
Australia & South Korea Diabetic Foot Ulcer Market is expected to reach US$ 313.53 billion by 2030
Sep 20, 2023
Companion Animal Specialty Drugs Market To Record Ascending Growth By 2027
Nov 26, 2020
See how South Africa Anti-Infective Market is Changes during 2019-2027 with an increase in Revenue of $2572.5Mn| Sanofi, Abbott, Pfizer
Oct 27, 2020
Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD
May 22, 2020
Follow us on
